Concepedia

Author

N.‐G. Ilbäck

National Food Administration

Also Known As

N G Ilbäck, N. G. Ilback, N. G. IlbÄCk, N. Ilbäck, N.-G. Ilback, N.-G. Ilbäck, N.G. Ilbäck, N.‐G. Ilbäck, NILS G. ILBÅCK, Nils Gunnar Ilbäck

26

Publications

817

Citations

18

H-Index

72

Concepts

All Affiliations

National Food AdministrationUppsala University HospitalUppsala University
NI

About

N.‐G. Ilbäck is an author at National Food Administration specializing in medicine, virology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

407

2

Health Sciences

3

3

108

3

Public Health

3

3

130

4

Education

1

1

119

5

Management

1

1

25

N.‐G. Ilbäck

×

19

Publications

728

Citations

17

H-Index

YearCitations

Scientific Opinion of the Panel on Additives and Products or Substances used in Animal Feed(FEEDAP) on a request from the European Commission on the safety and efficacy of AveMix® 02 CS/L (endo-1,3(4)-β-glucanase, endo-1,4-β-xylanase and pectinase) as feed additive for weaned piglets.

Efsa Panel on Additives, P.O.S.U.I.A.F.G. Aquilina, Georges Bories,

EFSA Journal

2009

119

Modifying effects of exercise on clinical course and biochemical response of the myocardium in influenza and tularemia in mice

N.‐G. Ilbäck, G Friman, W. R. Beisel,

Infection and Immunity

1984

54

Estimated intake of the artificial sweeteners acesulfame-K, aspartame, cyclamate and saccharin in a group of Swedish diabetics

N.‐G. Ilbäck, M. Alzin, S. Jahrl,

Food Additives & Contaminants

2003

54

Estimated dietary intake of nitrite and nitrate in Swedish children

Kristin Larsson, Per Ola Darnerud, N.‐G. Ilbäck,

Food Additives & Contaminants Part A

2011

51

Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.

N.‐G. Ilbäck, Jan Fohlman, S Slorach,

The Journal of Immunology

1989

49

Cardiovascular lipid accumulation with Coxsackie B virus infection in mice.

N.‐G. Ilbäck, Ahmed Mohammed, Jan Fohlman,

PubMed

1990

48

High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis.

Jan Fohlman, Karlis Pauksen, Brør Morein,

PubMed

1993

41

Does Fever or Myalgia Indicate Reduced Physical Performance Capacity in Viral Infections?

Göran Friman, James E. Wright, N.‐G. Ilbäck,

Acta Medica Scandinavica

1985

39

Do surface-active lipids in food increase the intestinal permeability to toxic substances and allergenic agents?

N.‐G. Ilbäck, Maria Nyblom, Johan Carlfors,

Medical Hypotheses

2004

34

The Effects of Strenuous Exercise on Infection with Francisella tularensis in Rats

G Friman, N.‐G. Ilbäck, W. R. Beisel,

The Journal of Infectious Diseases

1982

34

Page 1